Results 181 to 190 of about 58,926 (216)
Some of the next articles are maybe not open access.
Immunobiology of Helicobacter pylori infection
Current Opinion in Immunology, 1997Helicobacter pylori is a 'slow' bacterial pathogen. While infection is usually acquired early in life, only decades later does severe pathology appear. During this long period of incubation, the host mounts a vigorous immune response against H. pylori which fails to resolve the infection and may in fact contribute to the severity of the disease. In the
J L, Telford +3 more
openaire +2 more sources
Diagnosis of Helicobacter pylori infection
BMJ, 2012The article explores how to test for Helicobacter pylori infection and when to check whether treatment has ...
openaire +3 more sources
Pathogenesis of Helicobacter pylori infection
Current Opinion in Gastroenterology, 2000Helicobacter pylori, a gram-negative, microaerophilic, motile, spiral-shaped bacterium, has been established as the etiologic agent of gastritis and peptic ulcers and is a major risk factor for gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma (MALT). The ability of H.
D J, McGee, H L, Mobley
openaire +2 more sources
Helicobacter pylori infection: pathogenesis
Current Opinion in Gastroenterology, 2003This review covers progress in identifying Helicobacter pylori-derived factors that are involved in survival and virulence of the organism and in elucidating host response pathways that can limit the infection but are also susceptible to dysregulation.
Purvi C, Panchal +3 more
openaire +2 more sources
Treatment of Helicobacter pylori infection
Current Opinion in Gastroenterology, 2000Combination antimicrobial therapies for the effective eradication of Helicobacter pylori infection have been identified and are commercially available. Ongoing studies to improve eradication rates are based on modification of currently approved treatments. Management of H.
N, Vakil, M F, Go
openaire +2 more sources
New England Journal of Medicine, 2019
Key Clinical Points Helicobacter pylori Infection Testing for H. pylori is recommended in patients with peptic ulcer disease, gastric cancer, or gastric mucosa–associated lymphoid tissue lymphoma (...
openaire +2 more sources
Key Clinical Points Helicobacter pylori Infection Testing for H. pylori is recommended in patients with peptic ulcer disease, gastric cancer, or gastric mucosa–associated lymphoid tissue lymphoma (...
openaire +2 more sources
Pathogenesis of Helicobacter pylori infection
Springer Seminars in Immunopathology, 2005Helicobacter pylori induces chronic gastritis, the strongest known risk factor for peptic ulcer disease and distal gastric cancer, yet only a fraction of colonized individuals ever develop clinical disease. H. pylori isolates possess substantial genotypic diversity, which engenders differential host inflammatory responses that influence pathologic ...
openaire +2 more sources
Helicobacter pylori infection and diabetes.
Minerva medica, 2010The bacterium Helicobacter pylori (H. pylori), prime causal agent of gastroduodenal diseases, has been involved in various aspects of several extragastric manifestations. Although currently available data do not provide proof of its role in most of them, a potential relationship cannot be ruled out. In the present review, the consistency of a role of H.
Ojetti, Veronica +5 more
openaire +4 more sources
Current Opinion in Infectious Diseases, 2012
This review is aimed at describing the main findings of 2011 on the aspects of Helicobacter pylori-related gastric disease linked to CagA and to T-regulatory cells (Treg), and on the attempts to improve the treatment efficacy.Recent findings presented in this review are as follows: CagA interferes with tumor suppression; tolerance protects from H ...
openaire +2 more sources
This review is aimed at describing the main findings of 2011 on the aspects of Helicobacter pylori-related gastric disease linked to CagA and to T-regulatory cells (Treg), and on the attempts to improve the treatment efficacy.Recent findings presented in this review are as follows: CagA interferes with tumor suppression; tolerance protects from H ...
openaire +2 more sources
Helicobacter pylori infection in children
Current Problems in Pediatrics, 2001A number of scientific breakthroughs since H pylori first became recognized as a human pathogen have increased our understanding of the pathogenesis of gastroduodenal disease. In particular, advances in molecular bacteriology and the complete sequencing of the H pylori genome in 1999, and soon thereafter the human genome, provide tools allowing better ...
openaire +2 more sources